<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
58411-957-60
</NDCCode>
<PackageDescription>
1 TUBE in 1 BOX (58411-957-60) / 38 mL in 1 TUBE
</PackageDescription>
<NDC11Code>
58411-0957-60
</NDC11Code>
<ProductNDC>
58411-957
</ProductNDC>
<ProductTypeName>
HUMAN OTC DRUG
</ProductTypeName>
<ProprietaryName>
Cle De Peau Beaute Pore-refining Mattifying Veil
</ProprietaryName>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Avobenzone, Octinoxate, Octisalate, Octocrylene
</NonProprietaryName>
<DosageFormName>
PASTE
</DosageFormName>
<RouteName>
TOPICAL
</RouteName>
<StartMarketingDate>
20191201
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
OTC MONOGRAPH DRUG
</MarketingCategoryName>
<ApplicationNumber>
M020
</ApplicationNumber>
<LabelerName>
Shiseido Americas Corporation
</LabelerName>
<SubstanceName>
AVOBENZONE; OCTINOXATE; OCTISALATE; OCTOCRYLENE
</SubstanceName>
<StrengthNumber>
.9747; 2.885112; 1.9494; 1.16964
</StrengthNumber>
<StrengthUnit>
g/38mL; g/38mL; g/38mL; g/38mL
</StrengthUnit>
<Pharm_Classes/>
<DEASchedule/>
<Status>
Active
</Status>
<LastUpdate>
2026-02-05
</LastUpdate>
<PackageNdcExcludeFlag>
N
</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>
N
</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>
20271231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>
20191201
</StartMarketingDatePackage>
<EndMarketingDatePackage/>
<SamplePackage>
N
</SamplePackage>
</NDC>